SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-072949
Filing Date
2022-06-21
Accepted
2022-06-24 11:02:31
Documents
5
Period of Report
2022-07-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2217870-2_def14a.htm DEF 14A 173714
2 GRAPHIC lg_rubiustherapeut-4c.jpg GRAPHIC 200208
3 GRAPHIC sg_pablocagnoni-bw.jpg GRAPHIC 6899
4 GRAPHIC tm2217870d1-px_01pagebw.jpg GRAPHIC 245315
5 GRAPHIC tm2217870d1-px_02page4c.jpg GRAPHIC 525386
  Complete submission text file 0001104659-22-072949.txt   1500362
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38586 | Film No.: 221038479
SIC: 2836 Biological Products, (No Diagnostic Substances)